Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.71)
# 781
Out of 5,113 analysts
84
Total ratings
40.74%
Success rate
11.76%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORKA Oruka Therapeutics | Initiates: Overweight | $75 | $28.15 | +166.43% | 1 | Dec 18, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $140 → $72 | $6.43 | +1,019.75% | 2 | Nov 11, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $15 → $36 | $9.38 | +283.80% | 5 | Oct 28, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $400 → $540 | $544.41 | -0.81% | 4 | Oct 15, 2025 | |
| LBRX LB Pharmaceuticals | Initiates: Overweight | $78 | $19.70 | +295.94% | 1 | Oct 6, 2025 | |
| TENX Tenax Therapeutics | Initiates: Overweight | $20 | $12.82 | +56.01% | 1 | Sep 8, 2025 | |
| IVA Inventiva | Initiates: Overweight | $26 | $4.20 | +519.05% | 1 | Aug 27, 2025 | |
| PLRX Pliant Therapeutics | Maintains: Overweight | $17 → $4 | $1.21 | +230.58% | 2 | Aug 8, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $78 | $3.89 | +1,905.14% | 1 | Jun 12, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Overweight | $93 → $145 | $48.38 | +199.71% | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 | $21.15 | +141.13% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.18 | +408.47% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $18.91 | +153.83% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $78.88 | +17.90% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $29.86 | +151.17% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $44.00 | +138.64% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $33.90 | +9.14% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $4.27 | +508.90% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.57 | +4,841.76% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $45.14 | +114.89% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $269.26 | +0.27% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $18.37 | +313.72% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $5.05 | +395.05% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $11.38 | +163.62% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $9.01 | +33.19% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $5.40 | +1,566.67% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $7.82 | +2,201.79% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $3.43 | +337.32% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $6.06 | +164.03% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $47.53 | +68.31% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $62.45 | +48.92% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $26.18 | +117.72% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $5.96 | +1,024.16% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $85.79 | -59.20% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $14.53 | +498.76% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $10.37 | +1,587.56% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $62.20 | +15.76% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $7.74 | +545.99% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.67 | +5,888.02% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.37 | +4,779.37% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $13.80 | +2,943.48% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $70.28 | +9.56% | 1 | Jul 31, 2020 |
Oruka Therapeutics
Dec 18, 2025
Initiates: Overweight
Price Target: $75
Current: $28.15
Upside: +166.43%
Arcturus Therapeutics Holdings
Nov 11, 2025
Maintains: Overweight
Price Target: $140 → $72
Current: $6.43
Upside: +1,019.75%
Prothena Corporation
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $9.38
Upside: +283.80%
Madrigal Pharmaceuticals
Oct 15, 2025
Maintains: Overweight
Price Target: $400 → $540
Current: $544.41
Upside: -0.81%
LB Pharmaceuticals
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $19.70
Upside: +295.94%
Tenax Therapeutics
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $12.82
Upside: +56.01%
Inventiva
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $4.20
Upside: +519.05%
Pliant Therapeutics
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.21
Upside: +230.58%
Tvardi Therapeutics
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $3.89
Upside: +1,905.14%
Soleno Therapeutics
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $48.38
Upside: +199.71%
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $21.15
Upside: +141.13%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.18
Upside: +408.47%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $18.91
Upside: +153.83%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $78.88
Upside: +17.90%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $29.86
Upside: +151.17%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $44.00
Upside: +138.64%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $33.90
Upside: +9.14%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $4.27
Upside: +508.90%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.57
Upside: +4,841.76%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $45.14
Upside: +114.89%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $269.26
Upside: +0.27%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $18.37
Upside: +313.72%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $5.05
Upside: +395.05%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $11.38
Upside: +163.62%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $9.01
Upside: +33.19%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $5.40
Upside: +1,566.67%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $7.82
Upside: +2,201.79%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $3.43
Upside: +337.32%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $6.06
Upside: +164.03%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $47.53
Upside: +68.31%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $62.45
Upside: +48.92%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $26.18
Upside: +117.72%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $5.96
Upside: +1,024.16%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $85.79
Upside: -59.20%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $14.53
Upside: +498.76%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $10.37
Upside: +1,587.56%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $62.20
Upside: +15.76%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $7.74
Upside: +545.99%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.67
Upside: +5,888.02%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.37
Upside: +4,779.37%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $13.80
Upside: +2,943.48%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $70.28
Upside: +9.56%